Kieran O'Kane, Chief Commercial Officer at Biodesix Inc. ($BDSX), sold shares on the open market seven times over the past year, totaling about $15,711. His most recent sale occurred on February 23, 2026. These transactions rank 11,138th among 11,678 insiders in our database by sale value, compared to an average of $8.6 million per insider and about 6.4 sales. O'Kane made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1469 | $0.00 | 4,406.0000 | 7,954,541 | 25.00% | 0.02% |
| Feb. 20, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1469 | $0.00 | 10,354.0000 | 7,954,541 | 16.53% | 0.02% |
| Feb. 23, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 535 | $12.78 | 9,819.0000 | 7,954,541 | 5.17% | 0.01% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1527 | $0.00 | 1,526.0000 | 7,954,541 | 50.02% | 0.02% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 73 | $0.00 | 0.0000 | 7,954,541 | 100.00% | 0.00% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1600 | $0.00 | 9,469.0000 | 7,954,541 | 20.33% | 0.02% |
| Feb. 10, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 584 | $10.08 | 8,885.0000 | 7,954,541 | 6.17% | 0.01% |
| Jan. 15, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 805 | $0.00 | 8,167.0000 | 7,954,541 | 10.93% | 0.01% |
| Jan. 15, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 805 | $0.00 | 1,609.0000 | 7,954,541 | 33.35% | 0.01% |
| Jan. 16, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 298 | $8.15 | 7,869.0000 | 7,954,541 | 3.65% | 0.00% |
| Jan. 2, 2026 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Stock Options (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 7,954,541 | 9999.99% | 0.34% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 75 | $0.00 | 7,387.0000 | 7,954,541 | 1.03% | 0.00% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 25 | $7.62 | 7,362.0000 | 7,954,541 | 0.34% | 0.00% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 75 | $0.00 | 73.0000 | 7,954,541 | 50.68% | 0.00% |
| Aug. 12, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1489 | $0.00 | 2,979.0000 | 145,491,569 | 33.33% | 0.00% |
| Aug. 12, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1489 | $0.00 | 140,541.0000 | 145,491,569 | 1.07% | 0.00% |
| Aug. 13, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 476 | $0.42 | 140,065.0000 | 145,491,569 | 0.34% | 0.00% |
| May 9, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1490 | $0.00 | 4,468.0000 | 145,491,569 | 25.01% | 0.00% |
| May 9, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1490 | $0.00 | 139,529.0000 | 145,491,569 | 1.08% | 0.00% |
| May 12, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 239 | $0.36 | 139,290.0000 | 145,491,569 | 0.17% | 0.00% |
| May 13, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 238 | $0.35 | 139,052.0000 | 145,491,569 | 0.17% | 0.00% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Restricted Stock Units | 117500 | $0.00 | 117,500.0000 | 145,491,569 | 9999.99% | 0.08% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Stock Options (Right to buy) | 235000 | $0.00 | 235,000.0000 | 145,491,569 | 9999.99% | 0.16% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Stock Options (Right to buy) | 87319 | $0.00 | 87,319.0000 | 145,491,569 | 9999.99% | 0.06% |
| Feb. 11, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 17527 | $0.92 | 128,039.0000 | 145,491,569 | 12.04% | 0.01% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 30534 | $0.00 | 61,067.0000 | 145,491,569 | 33.33% | 0.02% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1489 | $0.00 | 5,958.0000 | 145,491,569 | 19.99% | 0.00% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 16095 | $0.00 | 48,286.0000 | 145,491,569 | 25.00% | 0.01% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 48118 | $0.00 | 145,566.0000 | 145,491,569 | 49.38% | 0.03% |
| Nov. 11, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 238 | $1.39 | 97,672.0000 | 96,235,883 | 0.24% | 0.00% |
| Nov. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1490 | $0.00 | 7,447.0000 | 96,235,883 | 16.67% | 0.00% |
| Nov. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1490 | $0.00 | 97,910.0000 | 96,235,883 | 1.55% | 0.00% |
| Nov. 12, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 224 | $1.40 | 97,448.0000 | 96,235,883 | 0.23% | 0.00% |
| Aug. 12, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 120 | $1.57 | 89,628.0000 | 96,235,883 | 0.13% | 0.00% |
| Aug. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1489 | $0.00 | 8,937.0000 | 96,235,883 | 14.28% | 0.00% |
| Aug. 9, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 345 | $1.60 | 89,748.0000 | 96,235,883 | 0.38% | 0.00% |
| Aug. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1489 | $0.00 | 90,093.0000 | 96,235,883 | 1.68% | 0.00% |
| May 23, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Series A Non-Voting Convertible Preferred Stock | 327 | $0.00 | 0.0000 | 96,235,883 | 100.00% | 0.00% |
| May 23, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 13080 | $0.00 | 88,604.0000 | 96,235,883 | 17.32% | 0.01% |
| May 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 1489 | $0.00 | 75,992.0000 | 96,235,883 | 2.00% | 0.00% |
| May 9, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 468 | $1.48 | 75,524.0000 | 96,235,883 | 0.62% | 0.00% |
| May 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1489 | $0.00 | 10,426.0000 | 96,235,883 | 12.50% | 0.00% |
| April 5, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Series A Non-Voting Convertible Preferred Stock | 327 | $46.00 | 327.0000 | 96,235,883 | 9999.99% | 0.00% |
| Feb. 21, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Stock Options (Right to buy) | 35307 | $0.00 | 35,307.0000 | 96,235,883 | 9999.99% | 0.04% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Common Stock | 32024 | $0.00 | 79,736.0000 | 96,235,883 | 67.12% | 0.03% |
| Feb. 9, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 6319 | $1.92 | 73,417.0000 | 96,235,883 | 7.92% | 0.01% |
| Feb. 12, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | S | Common Stock | 5412 | $1.66 | 68,005.0000 | 96,235,883 | 7.37% | 0.01% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Restricted Stock Units | 64381 | $0.00 | 64,381.0000 | 96,235,883 | 9999.99% | 0.07% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | A | Stock Options (Right to buy) | 128761 | $0.00 | 128,761.0000 | 96,235,883 | 9999.99% | 0.13% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 1490 | $0.00 | 11,915.0000 | 96,235,883 | 11.12% | 0.00% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | O'Kane Kieran | Chief Commercial Officer | M | Restricted Stock Units | 30534 | $0.00 | 91,601.0000 | 96,235,883 | 25.00% | 0.03% |